IIPLA News
Monday, August 3, 2026

BASF Enforces Patent on Saflufenacil Solid Form in Australia, Bolstering Crop Protection IP Rights

Australian court ruling affirms BASF’s patent on crystalline form of herbicide ingredient, reinforcing innovation incentives in agricultural technology

IIPLA News Deskanonymous access0 articles left this week
BASF Enforces Patent on Saflufenacil Solid Form in Australia, Bolstering Crop Protection IP Rights

On 3 August 2026, BASF achieved a significant legal victory in Australia by successfully enforcing its patent rights relating to a specific solid form of the herbicide active ingredient saflufenacil. This enforcement action highlights the company’s dedication to protecting its intellectual property portfolio within the crop protection sector, a field that demands substantial investment in research, product development, and regulatory compliance.

The patented crystalline form of saflufenacil is integral to BASF’s herbicide products Sharpen® and Voraxor®, which are formulated to assist farmers in managing challenging weed species across diverse cropping systems. BASF emphasizes that patents on particular crystalline forms of active ingredients are crucial for ensuring the stability, quality, and efficacy of crop protection products.

Parvana Wali, Head of BASF Agricultural Solutions Australia & New Zealand, stated that the company remains committed to delivering science-based crop protection technologies to Australian growers. She underscored that robust intellectual property protection is essential for sustaining long-term investments in the development of innovative agricultural solutions.

The enforcement outcome reinforces the growing importance of intellectual property rights within the global crop protection industry. As companies invest heavily in discovering and commercializing new active ingredients and formulations, patent protection and enforcement serve as vital mechanisms to encourage innovation and maintain a competitive marketplace.

BASF has indicated it will continue to monitor market activities closely and pursue appropriate legal measures to defend its intellectual property rights when necessary. This proactive stance aims to ensure ongoing availability of next-generation crop protection technologies that address evolving weed management challenges faced by growers.

The ruling also reflects broader industry trends where protecting specific crystalline forms of active ingredients can provide companies with a competitive edge by safeguarding product performance attributes.

This development follows other recent movements in the agricultural innovation space, such as ADAMA’s registration of Sierra®, the first off-patent, self-produced saflufenacil-based product in Australia, and Clean Seed’s U.S. patent allowance for residue management technology.

BASF’s enforcement success in Australia exemplifies the critical role of intellectual property rights in fostering an environment conducive to agricultural innovation, benefiting both industry stakeholders and end-users in the farming community.

As the crop protection sector continues to evolve, patent enforcement will remain a key factor in supporting research investments and delivering advanced solutions that meet the demands of sustainable and effective weed control.

For BASF and other industry players, maintaining a strong patent portfolio and vigilant enforcement strategies are essential components of their innovation and market leadership strategies in Australia and globally.

Share This Article
Ready-to-post copy includes the article link.

BASF Enforces Patent on Saflufenacil Solid Form in Australia, Bolstering Crop Protection IP Rights BASF has secured a successful enforcement of its patent covering a specific solid crystalline form of saflufenacil in Australia. The ruling protects BASF’s intellectual property in its Sharpen® and Voraxor® herbicides,... Read the full IIPLA article: https://iipla.org/news/basf-enforces-patent-on-saflufenacil-solid-form-in-australia-bolstering-crop-protection-ip-rights

Related Coverage

Continue in the newsroom

Back to newsroom
PatentsGlobal

Paul Weiss Expands Life Sciences Practice with Partner Ian Edvalson in San Francisco

Paul, Weiss, Rifkind, Wharton & Garrison has appointed Ian Edvalson as a partner in its San Francisco office, strengthening the firm’s life sciences transactions and intellectual property practices. Edvalson brings extensive experience advising biopharmaceutical and medical technology companies on licensing, collabora…

Friday, August 7, 2026
PatentsGlobal

Mexican Patent Law Overhaul Demands Early Strategic Planning from Applicants

In the first half of 2026, Mexico implemented sweeping patent reforms that significantly alter how patent applications are prepared, filed, and prosecuted. Key changes include a reduction in the number of substantive office actions and a mandated one-year examination timeline, compelling applicants to adopt earlier an…

Friday, August 7, 2026
PatentsGlobal

China Advances Comprehensive Pharmaceutical IP Protection with New Regulatory Frameworks

China’s pharmaceutical sector is rapidly evolving from generic manufacturing to innovative drug development, supported by a robust intellectual property protection system. Key measures including regulatory data protection, patent term extensions, patent linkage mechanisms, and strengthened judicial and administrative…

Friday, August 7, 2026
PatentsGlobal

T&G Global Posts Strong First-Half Results Driven by Premium Apple Sales

T&G Global reported a 2.6% revenue increase to $572.3 million for the six months ending June 30, 2024, led by a 6.1% rise in its Apples division revenue to $550.9 million. Operating profit grew 30% to $11.6 million before impairment adjustments related to the sale of T&G Fresh businesses. The company highlighted signi…

Friday, August 7, 2026